Insurance Barriers Limit Pulmonary Rehab Access
Insurance coverage is a significant barrier to accessing virtual pulmonary rehabilitation programs for people with COPD.
Insurance coverage is a significant barrier to accessing virtual pulmonary rehabilitation programs for people with COPD.
The FDA approved over-the-counter Mucinex 12hr Cold & Fever Multi-Symptom.
For patients in the pediatric ICU, pulse oximetry and waveform capnography are valuable tools to monitor the effectiveness of respiratory support and to inform treatment decisions.
Masimo has appointed Tim Benner as president, effective August 3, 2026, according to a company news release.
In kidney transplant recipients, early antiviral treatment with remdesivir reduced the risk of organ rejection and heart complications by nearly half for up to one year after diagnosis.
Wearable stickers can accurately measure sweat chloride levels in cystic fibrosis patients in under an hour without specialized laboratory equipment.
A closer look at some of the latest airway management and intubation devices from Dale Medical, Karl Storz, Marpac, Medline Industries, Neotech Products, and Olympus.